AELIVARSO Trademark

Trademark Overview

On Wednesday, June 17, 2020, a trademark application was filed for AELIVARSO with the United States Patent and Trademark Office. The USPTO has given the AELIVARSO trademark a serial number of 79290886. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, April 29, 2021. This trademark is owned by Helsinn Healthcare SA. The AELIVARSO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; anti-cancer compounds
aelivarso

General Information

Serial Number79290886
Word MarkAELIVARSO
Filing DateWednesday, June 17, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, April 29, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology; anti-cancer compounds

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHelsinn Healthcare SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events

Event DateEvent Description
Friday, October 16, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 6, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 11, 2020APPLICATION FILING RECEIPT MAILED
Monday, September 21, 2020ASSIGNED TO EXAMINER
Thursday, September 24, 2020NON-FINAL ACTION WRITTEN
Friday, September 25, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 16, 2020REFUSAL PROCESSED BY MPU
Thursday, April 29, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, November 8, 2020REFUSAL PROCESSED BY IB
Friday, July 19, 2024NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, May 24, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 29, 2021ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, January 12, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, January 12, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, January 29, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Friday, April 29, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 29, 2022FINAL DISPOSITION NOTICE SENT TO IB

Related Keywords

aelivarso cancer compounds anti oncology preparations pharmaceutical